Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Proshares Trust (ZBIO) Non-cash Items (2023 - 2025)

Historic Non-cash Items for Zenas BioPharma (ZBIO) over the last 3 years, with Q3 2025 value amounting to $98.1 million.

  • Zenas BioPharma's Non-cash Items rose 2390.53% to $98.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $98.1 million, marking a year-over-year increase of 2390.53%. This contributed to the annual value of $74.4 million for FY2024, which is 82033.65% up from last year.
  • Per Zenas BioPharma's latest filing, its Non-cash Items stood at $98.1 million for Q3 2025, which was up 2390.53% from $1.6 million recorded in Q2 2025.
  • In the past 5 years, Zenas BioPharma's Non-cash Items ranged from a high of $98.1 million in Q3 2025 and a low of $1.4 million during Q1 2025
  • Its 3-year average for Non-cash Items is $43.8 million, with a median of $41.2 million in 2023.
  • Per our database at Business Quant, Zenas BioPharma's Non-cash Items soared by 82033.65% in 2024 and then soared by 2390.53% in 2025.
  • Zenas BioPharma's Non-cash Items (Quarter) stood at $8.1 million in 2023, then skyrocketed by 820.34% to $74.4 million in 2024, then soared by 31.9% to $98.1 million in 2025.
  • Its Non-cash Items stands at $98.1 million for Q3 2025, versus $1.6 million for Q2 2025 and $1.4 million for Q1 2025.